Durable epigenetic silencing with a TALE-based editor

1. Mao, S. et al. Nat. Biotechnol. https://doi.org/10.1038/s41587-025-02838-y (2025).

   Article  PubMed  PubMed Central  Google Scholar

2. Amabile, A. et al. Cell 167219–232.E14 (2016).

   Article  CAS  PubMed  PubMed Central  Google Scholar

3. Bao, X. et al. Signal Transduct. Target. Ther. 913 (2024).

   Article  PubMed  PubMed Central  Google Scholar

4. Nuñez, JK et al. Cell 1842503–2519.E17 (2021).

   Article  PubMed  PubMed Central  Google Scholar

5. Tremblay, F. et al. Night. With. 311329–1338 (2025).

   Article  CAS  PubMed  PubMed Central  Google Scholar

6. Boch, j. et al. Science 3261509–1512 (2009).

   Article  CAS  PubMed  Google Scholar

7. Hou, X., Zaks, T., Langer, R. & Dong, Y. Night. Rev. Mater. 61078–1094 (2021).

   Article  CAS  PubMed  PubMed Central  Google Scholar

8. Hossein-Kharat, M., Bremmell, KE & Presidge, CA Mol. Ther. Methods Clin. Dev. 33101436 (2025).

   Article  CAS  PubMed  PubMed Central  Google Scholar

9. Ray, K. K. et al. N. Engl. J. Med. 3821507–1519 (2020).

   Article  CAS  PubMed  Google Scholar

10. Cappelluti, MA et al. Nature 627416–423 (2024).

    Article  CAS  PubMed  PubMed Central  Google Scholar

Download references

Authors and Affiliations

1. Department of Bioengineering, Stanford University, Stanford, CA, USA

   Tassilo L. A. Wachsmann & Lei S. Qi

2. Sarafan Chem-H, Stanford University, Stanford, Ca, USA

   Lei S. Qi

3. Chan Zuckerberg Biohub – San Francisco, San Francisco, CA, USA

   Lei S. Qi

Corresponding author

Correspondence to Lei S. Qi.

Competing interests

L.S.Q. is a founder of Epicrispr Biotechnologies and scientific advisor to the Laboratory of Genomic Research.